5/13
04:28 pm
uncy
Form 8-K Unicycive Therapeutics, For: May 13
Low
Report
Form 8-K Unicycive Therapeutics, For: May 13
5/13
04:07 pm
uncy
Form 10-Q Unicycive Therapeutics, For: Mar 31
Neutral
Report
Form 10-Q Unicycive Therapeutics, For: Mar 31
5/8
04:06 pm
uncy
Form DEFA14A Unicycive Therapeutics,
Medium
Report
Form DEFA14A Unicycive Therapeutics,
4/26
05:13 pm
uncy
Form ARS Unicycive Therapeutics, For: Dec 31
High
Report
Form ARS Unicycive Therapeutics, For: Dec 31
4/26
05:13 pm
uncy
Form DEFA14A Unicycive Therapeutics,
High
Report
Form DEFA14A Unicycive Therapeutics,
4/26
05:12 pm
uncy
Form DEF 14A Unicycive Therapeutics, For: Jun 20
High
Report
Form DEF 14A Unicycive Therapeutics, For: Jun 20
4/17
04:33 pm
uncy
Form 4 Unicycive Therapeutics, For: Apr 15 Filed by: Townsend John
Medium
Report
Form 4 Unicycive Therapeutics, For: Apr 15 Filed by: Townsend John
4/17
04:32 pm
uncy
Form 4 Unicycive Therapeutics, For: Apr 15 Filed by: Gupta Pramod
Medium
Report
Form 4 Unicycive Therapeutics, For: Apr 15 Filed by: Gupta Pramod
4/17
04:32 pm
uncy
Form 4 Unicycive Therapeutics, For: Apr 15 Filed by: Jermasek Douglas
Medium
Report
Form 4 Unicycive Therapeutics, For: Apr 15 Filed by: Jermasek Douglas
4/17
04:31 pm
uncy
Form 4 Unicycive Therapeutics, For: Apr 15 Filed by: Gupta Shalabh K.
Medium
Report
Form 4 Unicycive Therapeutics, For: Apr 15 Filed by: Gupta Shalabh K.
4/16
04:07 pm
uncy
Form PRE 14A Unicycive Therapeutics, For: Apr 16
Medium
Report
Form PRE 14A Unicycive Therapeutics, For: Apr 16
3/29
06:01 am
uncy
Form 8-K Unicycive Therapeutics, For: Mar 28
Low
Report
Form 8-K Unicycive Therapeutics, For: Mar 28
3/28
04:09 pm
uncy
Form 10-K Unicycive Therapeutics, For: Dec 31
Low
Report
Form 10-K Unicycive Therapeutics, For: Dec 31
3/20
05:10 pm
uncy
Form D Unicycive Therapeutics,
Medium
Report
Form D Unicycive Therapeutics,
3/14
04:28 pm
uncy
Form 8-K Unicycive Therapeutics, For: Mar 13
Medium
Report
Form 8-K Unicycive Therapeutics, For: Mar 13
3/14
04:01 pm
uncy
Form 8-K Unicycive Therapeutics, For: Mar 13
Low
Report
Form 8-K Unicycive Therapeutics, For: Mar 13